Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody

Cell Research

Volumn 25, Issue 5, 2015, Pages 604-620

  Gu, Ying ^a   Tang, Xuhua ^b,c   Zhang, Xiao ^a   Song, Cuiling ^a   Zheng, Minghua ^a   Wang, Kaihang ^a   Zhang, Jun ^a   Ng, Mun Hon ^a   Hew, Choy Leong ^b,d   Li, Shaowei ^a   Xia, Ningshao ^a   Sivaraman, J ^b  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cross genotype neutralizing antibody; epitope; HEV; immunodominant

Indexed keywords

ANIMALIA; HEPATITIS E VIRUS; HEPEVIRIDAE; MIRIDAE; RNA VIRUSES;

EPITOPE; NEUTRALIZING ANTIBODY;

ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PROCEDURES; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; IMMUNOLOGY; PATHOGENICITY; RHESUS MONKEY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; BIOSENSING TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; MACACA MULATTA;

EID: 84928926200     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.34     Document Type: Article

References (41)

1. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48:494-503
2. Tessari P, Sofia A, Saffioti S, et al. Effects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings. Gastroenterology 2010; 138:1557-1565
3. Petit MA, Capel F, Dubanchet S, Mabit H. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 1992; 187:211-222
4. Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001; 72:103-108
5. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 2007; 372:774-797
6. Deng Q, Zhai JW, Michel ML, et al. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site. J Virol 2007; 81:4244-4254
7. Pavio N, Renou C, Di Liberto G, Boutrouille A, Eloit M. Hepatitis E: a curious zoonosis. Front Biosci 2008; 13:7172-7183
8. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185:120-131
9. Yamashita T, Mori Y, Miyazaki N, et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci USA 2009; 106:12986-12991
10. Guu TS, Liu Z, Ye Q, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci USA 2009; 106:12992-12997
11. Li S, Tang X, Seetharaman J, et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009; 5:e1000537
12. Li SW, Zhang J, He ZQ, et al. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 2005; 280:3400-3406
13. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902
14. Zhang J, Ge SX, Huang GY, et al. Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 2003; 71:518-526
15. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-1027
16. Xing L, Kato K, Li T, et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology 1999; 265:35-45
17. Tang X, Yang C, Gu Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci USA 2011; 108:10266-10271
18. Zhang J, Gu Y, Ge SX, et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005; 23:2881-2892
19. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23:2893-2901
20. Chen Y, Qin K, Wu WL, et al. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 2009; 199:49-58
21. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40:1387-1395
22. McLellan JS, Pancera M, Carrico C, et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 2011; 480:336-343
23. Corti D, Voss J, Gamblin SJ, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011; 333:850-856
24. Ekiert DC, Friesen RH, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011; 333:843-850
25. Graham BS. Advances in antiviral vaccine development. Immunol Rev 2013; 255:230-242
26. Li F, Torresi J, Locarnini SA, et al. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J Med Virol 1997; 52:289-300
27. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367:1237-1244
28. Fransson J, Teplyakov A, Raghunathan G, et al. Human framework adaptation of a mouse anti-human IL-13 antibody. J Mol Biol 2010; 398:214-231
29. He S, Miao J, Zheng Z, et al. Putative receptor-binding sites of hepatitis E virus. J Gen Virol 2008; 89:245-249
30. Graff J, Zhou YH, Torian U, et al. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol 2008; 82:1185-1194
31. Xing L, Li TC, Mayazaki N, et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010; 285:33175-33183
32. Xing L, Wang JC, Li TC, et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol 2011; 85:1117-1124
33. Schofield DJ, Glamann J, Emerson SU, Purcell RH. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 2000; 74:5548-5555
34. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromol Crystallogr, Pt A 1997:307-326
35. Storoni LC, McCoy AJ, Read RJ. Likelihood-enhanced fast rotation functions. Acta Crystallogr D Biol Crystallogr 2004; 60:432-438
36. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126-2132
37. Brunger AT, Adams PD, Clore GM, et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998; 54:905-921
38. Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66:213-221
39. Laskowski RA, Macarthur MW, Moss DS, Thornton JM. PROCHECK -a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26:283-291
40. Delano W. The PyMOL molecular graphics system. San Carlos, CA: Schrödinger, available freom http://www.pymol.org/2002
41. Gouet P, Courcelle E, Stuart DI, Metoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 1999; 15:305-308